CHO Pharma Financials
| 6586 Stock | TWD 59.50 0.30 0.50% |
CHO |
Understanding current and past CHO Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CHO Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in CHO Pharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in CHO Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CHO Pharma. Check CHO Pharma's Beneish M Score to see the likelihood of CHO Pharma's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Benchmark | Dow Jones Industrial |
| Currency | TWD - New Taiwan Dollar |
You should never invest in CHO Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CHO Stock, because this is throwing your money away. Analyzing the key information contained in CHO Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CHO Pharma Key Financial Ratios
There are many critical financial ratios that CHO Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CHO Pharma reports annually and quarterly.CHO Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CHO Pharma's current stock value. Our valuation model uses many indicators to compare CHO Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CHO Pharma competition to find correlations between indicators driving CHO Pharma's intrinsic value. More Info.CHO Pharma is rated below average in number of employees category among its peers. It is number one stock in market capitalization category among its peers creating about 494,545,455 of Market Capitalization per Number Of Employees. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CHO Pharma's earnings, one of the primary drivers of an investment's value.CHO Pharma Systematic Risk
CHO Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CHO Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on CHO Pharma correlated with the market. If Beta is less than 0 CHO Pharma generally moves in the opposite direction as compared to the market. If CHO Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CHO Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CHO Pharma is generally in the same direction as the market. If Beta > 1 CHO Pharma moves generally in the same direction as, but more than the movement of the benchmark.
CHO Pharma February 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CHO Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CHO Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of CHO Pharma based on widely used predictive technical indicators. In general, we focus on analyzing CHO Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CHO Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.03 | |||
| Information Ratio | 0.0597 | |||
| Maximum Drawdown | 22.38 | |||
| Value At Risk | (3.34) | |||
| Potential Upside | 3.02 |
Additional Tools for CHO Stock Analysis
When running CHO Pharma's price analysis, check to measure CHO Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CHO Pharma is operating at the current time. Most of CHO Pharma's value examination focuses on studying past and present price action to predict the probability of CHO Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CHO Pharma's price. Additionally, you may evaluate how the addition of CHO Pharma to your portfolios can decrease your overall portfolio volatility.